BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company is approaching 100 patients successfully treated with the MicroThermX® Microwave Ablation System (MicroThermX®) at hospitals throughout the U.S. These successful treatments have generated a revenue stream from sales of disposable SynchroWave antennas combined with highly profitable, fee-per-use equipment rental revenues. BSD has added the equipment rental program to maximize revenues from the MicroThermX® line of products. Clinicians have used the MicroThermX® to treat patients with cancers of the liver, lung, and kidneys.
"We have expanded our sales programs for the MicroThermX® to include the rental program in order to increase our market penetration," said Harold Wolcott, BSD President and CEO. "This program has demonstrated the potential to significantly increase future revenues, and we are very optimistic about its success. We are also encouraged by the positive feedback from the clinicians, the market's acceptance of the product, and the ongoing positive clinical results from patient treatments with the MicroThermX®."
Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer